J. Goldman & Co’s Esperion Therapeutics ESPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-293,864
Closed -$1.83M 390
2022
Q4
$1.83M Sell
293,864
-259,146
-47% -$1.85M 0.09% 179
2022
Q3
$3.71M Buy
+553,010
New +$3.8M 0.18% 145
2021
Q2
Sell
-22,738
Closed -$638K 432
2021
Q1
$638K Sell
22,738
-19,172
-46% -$566K 0.02% 336
2020
Q4
$1.09M Buy
41,910
+28,707
+217% +$860K 0.06% 230
2020
Q3
$491K Sell
13,203
-52,347
-80% -$2.07M 0.03% 253
2020
Q2
$3.36M Buy
+65,550
New +$2.74M 0.21% 122
2020
Q1
Sell
-16,261
Closed -$970K 272
2019
Q4
$970K Buy
+16,261
New +$731K 0.07% 184
2018
Q4
Sell
-7,552
Closed -$335K 256
2018
Q3
$335K Sell
7,552
-85,139
-92% -$3.91M 0.02% 234
2018
Q2
$3.63M Buy
92,691
+41,444
+81% +$2.09M 0.19% 155
2018
Q1
$3.71M Buy
51,247
+36,670
+252% +$2.69M 0.16% 155
2017
Q4
$960K Sell
14,577
-15,443
-51% -$831K 0.05% 237
2017
Q3
$1.5M Sell
30,020
-9,980
-25% -$481K 0.08% 215
2017
Q2
$1.85M Buy
+40,000
New +$1.47M 0.1% 185
2017
Q1
Sell
-162,000
Closed -$2.03M 348
2016
Q4
$2.03M Buy
+162,000
New +$1.93M 0.13% 174

Other funds holding ESPR